全球角膜產品市場（2024）：2023-2029年分析

全球角膜產品市場（2024）新增福斯氏角膜內皮細胞失養症的全球市場機會相關部分，依地區分析福斯氏角膜內皮細胞失養症替代治療機會的潛在市場影響，並提供前10國家潛在市場的關鍵指標。

更新了六類 52 種疾病的角膜疾病人口的估計和預測，並修改了對可從角膜移植中受益的總人口的預測。

2024年角膜產品市場概覽概述了角膜疾病以及六種疾病類別的人口預測。討論了角膜產品和程序，包括角膜移植、治療水晶體、PTK、角膜內環段和角膜交聯，以及收入預測。也回顧了器官捐贈政策、法規和政策，以及角膜專家、眼庫和其他組織的角色。

本報告在其市場預測中考慮了來自50多家公司的70多種產品，同時也討論了即將推出的、其收入尚未預測的新技術。它還介紹了數百家眼庫、研究機構和非政府組織。還包括12個主要市場參與者的詳細公司簡介。

本報告涵蓋了整個角膜治療市場，網羅從疾病人口到生產產品的公司。

目錄

• 有關角膜疾病的資訊
• 角膜疾病族群現況及5年預測
• 外耳炎
• 角膜營養不良
• 先天性角膜疾病
• 後天性角膜疾病與外傷
• 傳染性角膜疾病
• 角膜炎
• 神經營養性角膜炎
• 其他角膜症候群和併發症
• 關於全球法規與器官移植環境的討論
• 有關眼科醫生、角膜專家和角膜移植外科醫生的資訊
• 光治療性角膜切除術地區預測
• 各地區治療鏡片預測
• 依地區的角膜內環節段預測
• 依地區的角膜交聯預測
• 依地區的角膜移植預測
• 依手術技術的角膜移植預測
• 依適應症的角膜移植預測
• 深入了解開發的新產品
• 關鍵產品與公司見解

What's New:

The "2024 Cornea Products Market Report" features a new section on the global market opportunity for Fuchs' dystrophy treatment, examining the potential market impact of alternate Fuchs' dystrophy treatment opportunity by region and presenting key metrics for the top 10 potential markets.

The report also includes updated estimates for population with corneal disease for six categories and 52 diseases and a revised forecast for the total population that could benefit from a cornea transplant, with breakouts for those with access to ophthalmic care and those who could benefit from upcoming therapies.

The "2024 Cornea Products Market Report" provides an overview of corneal diseases and gives estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also reviews organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.

This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 12 in-depth company profiles on key market players.

Contents:

This new report covers the entire cornea treatment landscape-from the diseased populations to the companies manufacturing the products. Our coverage includes:

• Information on corneal diseases
• Current and five-year estimates for the population with corneal diseases
• Ectasias
• Corneal dystrophies
• Congenital corneal disease
• Acquired corneal diseases and trauma
• Infectious corneal diseases
• Keratitis
• Neurotrophic keratitis
• Other corneal syndromes and complications
• Discussion on the global regulatory and organ transplantation environment
• Information on ophthalmologists, cornea specialists, and cornea transplant surgeons
• Forecasts for phototherapeutic keratectomy procedures by region
• Forecasts for therapeutic lenses by region
• Forecasts for intrastromal corneal ring segments by region
• Forecasts for corneal crosslinking by region
• Forecasts for cornea transplants by region
• Forecasts for cornea transplants by surgical technique
• Forecasts for cornea transplants by indication
• Discussion of new products in development
• Discussion of key products and companies